Erwin Mermelstein, MD - Medicare Cardiovascular Disease (cardiology) in East Brunswick, NJ

Erwin Mermelstein, MD is a medicare enrolled "Internal Medicine - Cardiovascular Disease" physician in East Brunswick, New Jersey. He went to Js Weill Medical College, Cornell University and graduated in 1978 and has 46 years of diverse experience with area of expertise as Cardiovascular Disease (cardiology). He is a member of the group practice Robert Wood Johnson Physician Enterprise, Robert Wood Johnson Medical Associates At Hamilton Pa and his current practice location is 593 Cranbury Road, Suite 2, East Brunswick, New Jersey. You can reach out to his office (for appointments etc.) via phone at (732) 390-3333.

Erwin Mermelstein is licensed to practice in New Jersey (license number MA04203400) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1538102843.

Contact Information

Erwin Mermelstein, MD
593 Cranbury Road, Suite 2,
East Brunswick, NJ 08816
(732) 390-3333
(732) 390-9244



Physician's Profile

Full NameErwin Mermelstein
GenderMale
SpecialityCardiovascular Disease (cardiology)
Experience46 Years
Location593 Cranbury Road, East Brunswick, New Jersey
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Erwin Mermelstein attended and graduated from Js Weill Medical College, Cornell University in 1978
  NPI Data:
  • NPI Number: 1538102843
  • Provider Enumeration Date: 06/14/2006
  • Last Update Date: 02/28/2017
  Medicare PECOS Information:
  • PECOS PAC ID: 5890684013
  • Enrollment ID: I20040611000071

Medical Identifiers

Medical identifiers for Erwin Mermelstein such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1538102843NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RC0000XInternal Medicine - Cardiovascular Disease MA04203400 (New Jersey)Primary
207RI0011XInternal Medicine - Interventional Cardiology 25MA04203400 (New Jersey)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Robert Wood Johnson University HospitalNew brunswick, NJHospital
Saint Peter's University HospitalNew brunswick, NJHospital
Centrastate Medical CenterFreehold, NJHospital
University Medical Center Of Princeton At PlainsboroPlainsboro, NJHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Robert Wood Johnson Physician Enterprise559791763347
Robert Wood Johnson Medical Associates At Hamilton Pa620480541933

News Archive

Qosina announces addition of new Control Stroke Syringes

Qosina is pleased to announce the addition of five new Control Stroke Syringes. These syringes help ensure volume regulation during fluid delivery, and are used for precise injection or withdrawal. All syringes are equipped with a dimple inside the barrel opposite the graduation, which acts as a plunger stop.

New research expands wearable brain scanner technology for whole head imaging

Scientists from the University of Nottingham developed an initial prototype of a new generation of brain scanner in 2018 which is a lightweight device that can be worn on the head like a hat, and can scan the brain even whilst a patient moves.

Bioenergetic analysis of pancreatic beta-cells shows impaired metabolic signature in type 2 diabetes patients

Impaired activation of mitochondrial energy metabolism in the presence of glucose has been demonstrated in pancreatic beta-cells from patients with type 2 diabetes. The cause of this dysfunction has been unknown. Publishing online in Endocrinology, Buck Institute assistant research professor Akos Gerencser, PhD, shows that in patients with type 2 diabetes the balance between supply and demand of the mitochondrial membrane potential (ΔψM) is altered causing a decrease in the signaling that turns on insulin secretion.

Patients treated for traumatic eye socket injuries at academic medical centers fare well at far less cost

Adding to evidence that "high-volume" specialty care in busy teaching hospitals leads to efficiencies unavailable in community hospitals, a new study by Johns Hopkins researchers finds that patients undergoing repair of traumatic eye socket injuries at its busy academic medical center fared just as well at far less cost than those treated at all other Maryland hospitals.

FDA accepts Teva Pharmaceutical Industries' BLA for XM02 G-CSF

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing Teva's Biologics License Application (BLA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Erwin Mermelstein allows following entities to bill medicare on his behalf.
Entity NameRobert Wood Johnson Medical Associates At Hamilton Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1619206828
PECOS PAC ID: 6204805419
Enrollment ID: O20040924000847

News Archive

Qosina announces addition of new Control Stroke Syringes

Qosina is pleased to announce the addition of five new Control Stroke Syringes. These syringes help ensure volume regulation during fluid delivery, and are used for precise injection or withdrawal. All syringes are equipped with a dimple inside the barrel opposite the graduation, which acts as a plunger stop.

New research expands wearable brain scanner technology for whole head imaging

Scientists from the University of Nottingham developed an initial prototype of a new generation of brain scanner in 2018 which is a lightweight device that can be worn on the head like a hat, and can scan the brain even whilst a patient moves.

Bioenergetic analysis of pancreatic beta-cells shows impaired metabolic signature in type 2 diabetes patients

Impaired activation of mitochondrial energy metabolism in the presence of glucose has been demonstrated in pancreatic beta-cells from patients with type 2 diabetes. The cause of this dysfunction has been unknown. Publishing online in Endocrinology, Buck Institute assistant research professor Akos Gerencser, PhD, shows that in patients with type 2 diabetes the balance between supply and demand of the mitochondrial membrane potential (ΔψM) is altered causing a decrease in the signaling that turns on insulin secretion.

Patients treated for traumatic eye socket injuries at academic medical centers fare well at far less cost

Adding to evidence that "high-volume" specialty care in busy teaching hospitals leads to efficiencies unavailable in community hospitals, a new study by Johns Hopkins researchers finds that patients undergoing repair of traumatic eye socket injuries at its busy academic medical center fared just as well at far less cost than those treated at all other Maryland hospitals.

FDA accepts Teva Pharmaceutical Industries' BLA for XM02 G-CSF

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing Teva's Biologics License Application (BLA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.

Read more Medical News

› Verified 7 days ago

Entity NameRobert Wood Johnson Physician Enterprise
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1245587922
PECOS PAC ID: 5597917633
Enrollment ID: O20121218000345

News Archive

Qosina announces addition of new Control Stroke Syringes

Qosina is pleased to announce the addition of five new Control Stroke Syringes. These syringes help ensure volume regulation during fluid delivery, and are used for precise injection or withdrawal. All syringes are equipped with a dimple inside the barrel opposite the graduation, which acts as a plunger stop.

New research expands wearable brain scanner technology for whole head imaging

Scientists from the University of Nottingham developed an initial prototype of a new generation of brain scanner in 2018 which is a lightweight device that can be worn on the head like a hat, and can scan the brain even whilst a patient moves.

Bioenergetic analysis of pancreatic beta-cells shows impaired metabolic signature in type 2 diabetes patients

Impaired activation of mitochondrial energy metabolism in the presence of glucose has been demonstrated in pancreatic beta-cells from patients with type 2 diabetes. The cause of this dysfunction has been unknown. Publishing online in Endocrinology, Buck Institute assistant research professor Akos Gerencser, PhD, shows that in patients with type 2 diabetes the balance between supply and demand of the mitochondrial membrane potential (ΔψM) is altered causing a decrease in the signaling that turns on insulin secretion.

Patients treated for traumatic eye socket injuries at academic medical centers fare well at far less cost

Adding to evidence that "high-volume" specialty care in busy teaching hospitals leads to efficiencies unavailable in community hospitals, a new study by Johns Hopkins researchers finds that patients undergoing repair of traumatic eye socket injuries at its busy academic medical center fared just as well at far less cost than those treated at all other Maryland hospitals.

FDA accepts Teva Pharmaceutical Industries' BLA for XM02 G-CSF

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing Teva's Biologics License Application (BLA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Erwin Mermelstein is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Erwin Mermelstein, MD
593 Cranbury Road, Suite 2,
East Brunswick, NJ 08816

Ph: (732) 390-3333
Erwin Mermelstein, MD
593 Cranbury Road, Suite 2,
East Brunswick, NJ 08816

Ph: (732) 390-3333

News Archive

Qosina announces addition of new Control Stroke Syringes

Qosina is pleased to announce the addition of five new Control Stroke Syringes. These syringes help ensure volume regulation during fluid delivery, and are used for precise injection or withdrawal. All syringes are equipped with a dimple inside the barrel opposite the graduation, which acts as a plunger stop.

New research expands wearable brain scanner technology for whole head imaging

Scientists from the University of Nottingham developed an initial prototype of a new generation of brain scanner in 2018 which is a lightweight device that can be worn on the head like a hat, and can scan the brain even whilst a patient moves.

Bioenergetic analysis of pancreatic beta-cells shows impaired metabolic signature in type 2 diabetes patients

Impaired activation of mitochondrial energy metabolism in the presence of glucose has been demonstrated in pancreatic beta-cells from patients with type 2 diabetes. The cause of this dysfunction has been unknown. Publishing online in Endocrinology, Buck Institute assistant research professor Akos Gerencser, PhD, shows that in patients with type 2 diabetes the balance between supply and demand of the mitochondrial membrane potential (ΔψM) is altered causing a decrease in the signaling that turns on insulin secretion.

Patients treated for traumatic eye socket injuries at academic medical centers fare well at far less cost

Adding to evidence that "high-volume" specialty care in busy teaching hospitals leads to efficiencies unavailable in community hospitals, a new study by Johns Hopkins researchers finds that patients undergoing repair of traumatic eye socket injuries at its busy academic medical center fared just as well at far less cost than those treated at all other Maryland hospitals.

FDA accepts Teva Pharmaceutical Industries' BLA for XM02 G-CSF

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing Teva's Biologics License Application (BLA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.

Read more News

› Verified 7 days ago


Internal Medicine Doctors in East Brunswick, NJ

Ellen A Ronnen, MD
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 629 Cranbury Rd Fl 2, East Brunswick, NJ 08816
Phone: 732-390-7750    Fax: 732-390-7725
Dr. Alan Sheldon Lichtbroun, M.D.
Cardiovascular Disease
Medicare: Medicare Enrolled
Practice Location: 63 Brunswick Woods Dr, East Brunswick, NJ 08816
Phone: 732-613-1900    Fax: 732-613-0029
Dr. Francis C D'mello, M.D.
Cardiovascular Disease
Medicare: Not Enrolled in Medicare
Practice Location: 385 State Route 18, West Ferris Plaza Unit K, East Brunswick, NJ 08816
Phone: 732-238-4343    Fax: 732-238-6981
Dr. Jose C Costa, MD
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 465 Cranbury Rd, Suite 102, East Brunswick, NJ 08816
Phone: 732-390-1995    Fax: 732-254-4610
Dr. Mervat B Mansour, M.D.
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 2 Auer Ct Ste D, East Brunswick, NJ 08816
Phone: 732-257-5530    Fax: 732-257-5531
Dr. Marsha Kallich, MD
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 579a Cranbury Rd, Suite 102, East Brunswick, NJ 08816
Phone: 732-613-0711    Fax: 732-613-5783
Raafat Ghobraiel, M.D.
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 79 Brunswick Woods Dr, East Brunswick, NJ 08816
Phone: 732-254-7778    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.